Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 8/25/14  and contains information from public web pages.

Dr. Jeffrey Elias

Wrong Dr. Jeffrey Elias?


Phone: (434) ***-****  HQ Phone
Email: j***@***.edu
University of Virginia
100 10Th Street NE Suite 103
Charlottesville , Virginia 22901
United States

Company Description: The University of Virginia was founded in 1819 by Thomas Jefferson. The cornerstone of the University's first building was laid in 1817, with Thomas Jefferson,...   more

Employment History

  • Lead Investigator
    University of Virginia
  • Assistant Professor of Neurosurgery and Director of the Functional Neurosurgery Program
    University of Virginia
  • Study's Principal Investigator and Director
  • Associate Professor of Neurological Surgery and Neurology and Director
  • Neurosurgeon

Board Memberships and Affiliations

  • Director


  • MD
    University of Virginia
  • M.D.
  • MD
  • M.D
    University of Virginia
86 Total References
Web References
UVA neurosurgeon Jeffrey ..., 25 Aug 2014 [cached]
UVA neurosurgeon Jeffrey Elias, MD, first tested focused ultrasound in 15 volunteers with essential tremor, a common movement disorder. All 15 reported "significant improvement" in their hand tremor and in their quality of life. Elias has since launched a larger, international trial and is also evaluating the technology for its potential to reduce shaking associated with Parkinson's disease.
??"We are very pleased to report ..., 26 Sept 2013 [cached]
??"We are very pleased to report these findings, and the publication of the study in the New England Journal of Medicine validates the significance of the study even though it is a very early stage investigation," said UVA's Jeffrey Elias, MD, the lead investigator of the study.
Elias is also conducting an initial clinical trial at UVA to test focused ultrasound's potential to reduce tremor in people with medication-resistant Parkinson's disease.
UVa Health System Doctors Study Surgery To Stop Epileptic Seizures, 6 June 2005 [cached]
,We now have very sophisticated means for identifying abnormal regions of activity in the brain, which has increased our ability to surgically treat epilepsy effectively,, said Dr. Jeff Elias, assistant professor of neurosurgery and director of the Functional Neurosurgery Program at UVa.
W. Jeffrey Elias, ..., 11 Dec 2013 [cached]
W. Jeffrey Elias, MD Associate Professor of Neurological Surgery and Neurology Director of Stereotactic and Functional Neurosurgery
Letters From You, 3 Oct 2011 [cached]
WASHINGTON, DC (October 3, 2011) - In a presentation at the Congress of Neurological Surgeons today, University of Virginia neurosurgeon W. Jeffrey Elias, MD reported that preliminary results of a pilot clinical trial indicate that MR-guided focused ultrasound has the potential to safely and effectively control essential tremor (ET), a common neurological condition that affects 10 million Americans.
Results from the study's first 10 patients showed a 78 percent improvement in contralateral tremor scores in the hand, as assessed with the Clinical Rating Scale for Tremor (CRST). Patients' functional activities scores improved by 92 percent, as measured in the 'Disability' subsection of the CRST. Outcomes and complications were comparable to other procedures for tremor, including stereotactic thalamotomy and deep brain stimulation.
"So far, this noninvasive treatment has been life-changing for patients," said Elias, the study's principal investigator and Director of Stereotactic and Functional Neurosurgery at UVA.
Most study participants have had ET for decades, Elias reported. As part of the study's inclusion criteria, all had previously taken at least two medications that failed to control their tremor. Despite the severity of their disability, patients had opted to cope with symptoms rather than undergo invasive surgical procedures.
Conducted under an FDA-approved protocol, the single-arm, non-randomized, phase 1 study began in February 2011 and is expected to treat 15 patients before concluding. All patients are being followed for three months. If final results prove successful, Elias anticipates launching a larger, pivotal trial to study the overall safety and long-term efficacy of MR-guided focused ultrasound in treating medication-refractory ET.
Other People with the name "Elias":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.